2-(3-Hydroxy-1-Adamantyl)-2-Oxoacetic Acid CAS 709031-28-7 Purity > 99.0% (HPLC)
Ruifu Chemical Supply Related Intermediates
CAS Nr .: 361442-04-8
CAS Nr .: 945667-22-1
(R)-1-Boc-3-Aminopiperidine CAS 188111-79-7
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
Boc-3-Hydroxy-1-Adamantyl-D-Glycine CAS 361442-00-4
Tom ntej: 1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo [3.1.0]hexane-2-Carboxylic Acid Tert-Butyl Ester CAS 361440-67-7
2-(3-Hydroxy-1-Adamantyl)-2-Oxoacetic Acid CAS 709031-28-7
Tshuaj npe | 2-(3-Hydroxy-1-Adamantyl)-2-Oxoacetic Acid |
Synonyms | 3-Hydroxy- α-Oxoadamantane-1-Acetic Acid;3-Hydroxy-Alpha-Oxoadamantane-1-Acetic Acid;2-(3-Hydroxyadamantan-1-yL)-2-Oxoacetic Acid;3-Hydroxy-α-Oxotricyclo[3.3.1.13,7]decane-1-Acetic Acid |
CAS Nr | 709031-28-7 |
CAT Number | Qauv TSIS MUAJ: RF-PI2288 |
Tshuag xwm txheej | Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons |
Molecular Formula | C12H16O4 |
Molecular Luj | 224.26 Nws |
Qhov ntom | 1.477 ib |
Hom | Ruifu Tshuaj |
Yam khoom | Specifications |
Qhov tshwm sim | Dawb rau Off-White Crystal Powder (Visual) |
Kev txheeb xyuas HPLC | Lub Sijhawm Tuav Tseg ntawm Cov Peak Loj Tau Txais los ntawm Cov Qauv Txheej Txheem yog sib haum rau Cov Qauv Siv |
Melting Point | 162.0 ~ 166.0 ℃ |
Dej (los ntawm Karl Fischer) | <0.50% (USP<921>) |
Purity / Analysis Method | > 99.0% (HPLC) |
Assay | 98.0% ~ 102.0% (Nyob rau hauv qhuav) |
Test Standard | Enterprise Standard |
Kev siv | API API (CAS: 361442-04-8) |
Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj
Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo
2-(3-Hydroxy-1-Adamantyl)-2-Oxoacetic Acid (CAS: 709031-28-7) yog ib qho nruab nrab ntawm API (CAS: 361442-04-8), uas yog hom 2 tshuaj ntshav qab zib uas tuaj yeem txhawb nqa pancreas tsim cov tshuaj insulin ntau dua tom qab noj mov.Nws tau mus txog los ntawm kev koom tes ntawm AstraZeneca thiab Bristol-Myers Squibb Company thiab belongs rau DPP-IV inhibitor.Nws ua lub luag haujlwm los ntawm inhibiting GLP-l degradation.GLP-I yog cov tshuaj hormones tsim nyob rau hauv txoj hnyuv tom qab noj mov.Nws tuaj yeem tswj hwm qhov tso tawm ntawm insulin thiab ntxiv dag zog rau kev siv cov piam thaj hauv cov ntaub so ntswg peripheral.